Quick answers
- What is Teflaro?
- Teflaro is a brand name of Ceftaroline fosamil, a prescription medicine. The FDA NDC Directory lists 2 Teflaro products in 2 strengths and forms.
- Who makes Teflaro?
- Abbvie holds the FDA application for Teflaro (NDA200327, approved October 29, 2010).
- Is there a generic or store brand of Teflaro?
- Other products of Ceftaroline fosamil are listed with the FDA, but none in exactly the same strength and form as a Teflaro product.
- Has Teflaro been recalled?
- No recall linked to Teflaro products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Teflaro is
Each Teflaro product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Ceftaroline fosamil · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| ceftaroline fosamil 400 mg/20 mL powder, for solution (intravenous) | Teflaro | None listed | DailyMed |
| ceftaroline fosamil 600 mg/20 mL powder, for solution (intravenous) | Teflaro | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Ceftaroline fosamil →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA200327 | Abbvie | October 29, 2010 | 2 |
Companies that list Teflaro
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Teflaro products.
- Allergan, Inc.2 products
Recalls
No recall linked to Teflaro products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.